SCHEMBL18484339

SCHEMBL18484339

COc1nc(C)nc2c1c(C#N)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.52
PAX8 Q06710 1/20 0.52
ALDH1A1 P00352 3/20 0.45
ADK P55263 4/20 0.45
DOT1L Q8TEK3 2/20 0.45
ADORA3 P0DMS8 3/20 0.43
ADORA1 P30542 3/20 0.43
ADORA2A P29274 3/20 0.42
ADORA2B P29275 1/20 0.42
SLC29A1 Q99808 1/20 0.40
TP53 P04637 2/20 0.39
HTT P42858 2/20 0.39
GMNN O75496 1/20 0.39
LMNA P02545 1/20 0.39
NFKB1 P19838 1/20 0.39
DNMT1 P26358 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11529405 0.89 HIF1A (0.51) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL18484348 0.86 HIF1A (0.54) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL22159896 0.86 HIF1A (0.54) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL18483493 0.85 DOT1L (0.56) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL18486808 0.85 DOT1L (0.56) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL18483520 0.85 HIF1A (0.53) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL7106108 0.84 HIF1A (0.65) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL7106111 0.84 HIF1A (0.65) HIF1APAX8ALDH1A1ADKDOT1L
SCHEMBL18483661 0.84 ADK (0.54) HIF1AALDH1A1ADKADORA3ADORA1
SCHEMBL18483858 0.82 ALDH1A1 (0.47) HIF1APAX8ALDH1A1ADKADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220002335-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2022-01-06 US disclosed
US-10941175-B2 Pyrrolopyrimidine nucleosides and analogs thereof CHIMERIX, INC. (US) 2021-03-09 US disclosed
US-20200199167-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2020-06-25 US disclosed
US-10407457-B2 Pyrrolopyrimidine nucleosides and analogs thereof CHIMERIX, INC. (US) 2019-09-10 US disclosed
US-20170253628-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2017-09-07 US disclosed
US-9708359-B2 Pyrrolopyrimidine nucleosides and analogs thereof CHIMERIX, INC. (US) 2017-07-18 US disclosed
US-9701706-B2 Pyrrolopyrimidine nucleosides and analogs thereof CHIMERIX, INC. (US) 2017-07-11 US disclosed
US-20170137454-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2017-05-18 US disclosed
US-20170044202-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2017-02-16 US disclosed
WO-2017024310-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF USEFUL AS ANTIVIRAL AGENTS CHIMERIX, INC. (US) 2017-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10407457-B2 Pyrrolopyrimidine nucleosides and analogs thereof TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885
US-20200199167-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885
US-20220002335-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885
US-20170137454-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885
US-20170253628-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885
US-20170044202-A1 PYRROLOPYRIMIDINE NUCLEOSIDES AND ANALOGS THEREOF TYMP, ITPA, IMPDH1 HIF1A 3680/4885PAX8 3838/4885ALDH1A1 1417/4885
US-10941175-B2 Pyrrolopyrimidine nucleosides and analogs thereof TYMP, PNP, DPYD HIF1A 3466/4885PAX8 4156/4885ALDH1A1 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.